Sunshine Biopharma (SBFM) Times Interest Earned (2016 - 2024)
Historic Times Interest Earned for Sunshine Biopharma (SBFM) over the last 11 years, with Q4 2024 value amounting to -$238.92.
- Sunshine Biopharma's Times Interest Earned fell 50593.5% to -$238.92 in Q4 2024 from the same period last year, while for Sep 2025 it was -$759.14, marking a year-over-year decrease of 112911.01%. This contributed to the annual value of -$662.43 for FY2024, which is 180074.47% down from last year.
- As of Q4 2024, Sunshine Biopharma's Times Interest Earned stood at -$238.92, which was down 50593.5% from -$5176.6 recorded in Q2 2024.
- Sunshine Biopharma's Times Interest Earned's 5-year high stood at -$1.99 during Q2 2021, with a 5-year trough of -$858990.0 in Q3 2022.
- Its 5-year average for Times Interest Earned is -$48104.3, with a median of -$26.56 in 2024.
- Per our database at Business Quant, Sunshine Biopharma's Times Interest Earned crashed by 810913781.94% in 2022 and then surged by 9999.76% in 2023.
- Over the past 5 years, Sunshine Biopharma's Times Interest Earned (Quarter) stood at -$3.26 in 2020, then crashed by 134.44% to -$7.63 in 2021, then plummeted by 11429.02% to -$880.12 in 2022, then soared by 95.52% to -$39.43 in 2023, then tumbled by 505.93% to -$238.92 in 2024.
- Its last three reported values are -$238.92 in Q4 2024, -$5176.6 for Q2 2024, and -$27.46 during Q1 2024.